Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues

Sebastian Oltean; Richard Coward; Massimo Collino; Hans Baelde

doi:10.1155/2017/3146524

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues

Sebastian Oltean, Richard Coward, Massimo Collino, Hans Baelde

Research output: Contribution to journal › Editorial (Academic Journal) › peer-review

9 Citations (Scopus)

245 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Article number	3146524
Number of pages	1
Journal	BioMed Research International
Volume	2017
DOIs	https://doi.org/10.1155/2017/3146524
Publication status	Published - 22 Nov 2017

Access to Document

10.1155/2017/3146524

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Biomed Research International at https://doi.org/10.1155/2017/3146524 . Please refer to any applicable terms of use of the publisher.
Final published version, 1.24 MBLicence: CC BY

2 Finished

Anti-angiogenic compounds based on modulation of VEGF splicing
Oltean, S.
1/10/16 → 1/02/17
Project: Research
mRNA splicing control in diabetes: a novel therapeutic strategy for the treatment of diabetic nephropathy
Oltean, S.
1/08/15 → 31/07/18
Project: Research

Cite this

@article{76aa8caf95bd4691aac4464dccc89734,

title = "Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues",

abstract = "[no abstract]",

author = "Sebastian Oltean and Richard Coward and Massimo Collino and Hans Baelde",

year = "2017",

month = nov,

day = "22",

doi = "10.1155/2017/3146524",

language = "English",

volume = "2017",

journal = "BioMed Research International",

issn = "2314-6133",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Diabetic Nephropathy

T2 - Novel Molecular Mechanisms and Therapeutic Avenues

AU - Oltean, Sebastian

AU - Coward, Richard

AU - Collino, Massimo

AU - Baelde, Hans

PY - 2017/11/22

Y1 - 2017/11/22

N2 - [no abstract]

AB - [no abstract]

U2 - 10.1155/2017/3146524

DO - 10.1155/2017/3146524

M3 - Editorial (Academic Journal)

C2 - 29359147

VL - 2017

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 3146524

ER -

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues

Abstract

Access to Document

Fingerprint

Projects

Anti-angiogenic compounds based on modulation of VEGF splicing

mRNA splicing control in diabetes: a novel therapeutic strategy for the treatment of diabetic nephropathy

Cite this